Aprea Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Aprea Therapeutics, Inc. (APRE) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$280.53 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$98.75K.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$181.78K.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $735.65K, a 48.55% increase year-over-year.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$170.00K.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $217.91K, a 125.40% increase from fiscal 2024.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $96.67K.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$451.99K.
- Aprea Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.19M, a 2103.04% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$98.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$280.53K 10-Q · filed 2026-08-12 | $455.12K derived: sum of 3 quarters · filed 2026-08-12 | $285.12K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$181.78K 10-Q · filed 2026-05-13 | $553.87K derived: sum of 2 quarters · filed 2026-05-13 | $383.88K derived: sum of 3 quarters · filed 2026-05-13 | $217.17K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $735.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $565.65K derived: sum of 2 quarters · filed 2026-03-16 | $398.95K derived: sum of 3 quarters · filed 2026-08-12 | $217.91K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$336.70K derived: sum of 2 quarters · filed 2026-08-12 | -$517.75K 10-Q · filed 2025-11-12 | -$22.54K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$166.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$347.75K 10-Q · filed 2026-08-12 | $147.46K derived: sum of 3 quarters · filed 2026-08-12 | -$474.37K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$181.04K 10-Q · filed 2026-05-13 | $314.16K derived: sum of 2 quarters · filed 2026-05-13 | -$307.67K derived: sum of 3 quarters · filed 2026-05-13 | $129.27K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $495.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$126.62K derived: sum of 2 quarters · filed 2026-03-16 | $310.31K derived: sum of 3 quarters · filed 2026-03-16 | $96.67K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$621.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$184.89K derived: sum of 2 quarters · filed 2025-11-12 | -$398.53K 10-Q · filed 2025-11-12 | $226.61K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $436.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $223.30K 10-Q · filed 2025-08-12 | $848.44K derived: sum of 3 quarters · filed 2025-08-12 | $181.55K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$213.64K 10-Q · filed 2025-05-14 | $411.50K derived: sum of 2 quarters · filed 2025-05-14 | -$255.39K derived: sum of 3 quarters · filed 2025-05-14 | -$321.58K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $625.14K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$41.75K derived: sum of 2 quarters · filed 2025-03-25 | -$107.94K derived: sum of 3 quarters · filed 2025-03-25 | -$451.99K 10-K · filed 2025-03-25 |
| 2023-09-30 | -$666.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$733.08K derived: sum of 2 quarters · filed 2024-11-07 | -$1.08M 10-Q · filed 2024-11-07 | -$100.72K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$66.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$410.25K 10-Q · filed 2024-08-12 | $566.17K derived: sum of 3 quarters · filed 2024-08-12 | -$473.49K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$344.06K 10-Q · filed 2024-05-14 | $632.36K derived: sum of 2 quarters · filed 2024-05-14 | -$407.30K derived: sum of 3 quarters · filed 2024-05-14 | -$1.42M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $976.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$63.24K derived: sum of 2 quarters · filed 2024-03-26 | -$1.07M derived: sum of 3 quarters · filed 2024-03-26 | -$2.19M 10-K · filed 2024-03-26 |
| 2022-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.05M derived: sum of 2 quarters · filed 2023-11-09 | -$3.17M 10-Q · filed 2023-11-09 | -$409.08K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.13M 10-Q · filed 2023-08-10 | $630.58K derived: sum of 3 quarters · filed 2024-03-26 | -$112.94K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | -$1.12M 10-Q · filed 2023-05-15 | $1.64M derived: sum of 2 quarters · filed 2024-03-26 | $898.64K derived: sum of 3 quarters · filed 2024-03-26 | -$74.35K derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $2.01M derived: sum of 2 quarters · filed 2024-03-26 | $1.04M derived: sum of 3 quarters · filed 2024-03-26 | $109.34K 10-K · filed 2024-03-26 |
| 2021-09-30 | -$743.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.72M derived: sum of 2 quarters · filed 2022-11-09 | -$2.65M 10-Q · filed 2022-11-09 | -$476.89K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$972.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$1.90M 10-Q · filed 2022-08-12 | $266.64K derived: sum of 3 quarters · filed 2023-03-30 | $48.49K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | -$931.58K 10-Q · filed 2022-05-16 | $1.24M derived: sum of 2 quarters · filed 2023-03-30 | $1.02M derived: sum of 3 quarters · filed 2023-03-30 | $405.76K derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.95M derived: sum of 2 quarters · filed 2023-03-30 | $1.34M derived: sum of 3 quarters · filed 2023-03-30 | $472.40K 10-K · filed 2023-03-30 |
| 2020-09-30 | -$218.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$833.86K derived: sum of 2 quarters · filed 2021-11-08 | -$1.70M 10-Q · filed 2021-11-08 | $887.95K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$615.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.48M 10-Q · filed 2021-08-12 | $1.11M derived: sum of 3 quarters · filed 2022-03-15 | $1.17M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$864.94K 10-Q · filed 2021-05-06 | $1.72M derived: sum of 2 quarters · filed 2022-03-15 | $1.79M derived: sum of 3 quarters · filed 2022-03-15 | $1.83M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.65M derived: sum of 2 quarters · filed 2022-03-15 | $2.69M derived: sum of 3 quarters · filed 2022-03-15 | $2.63M 10-K · filed 2022-03-15 |
| 2019-09-30 | $66.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $104.91K derived: sum of 2 quarters · filed 2020-11-06 | $46.98K 10-Q · filed 2020-11-06 | $150.51K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $38.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$19.72K 10-Q · filed 2020-08-11 | $83.81K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2019-03-31 | -$57.93K 10-Q · filed 2020-05-15 | $45.60K derived: sum of 2 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $103.53K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $19.45K 10-K · filed 2021-03-16 | ||
| 2018-09-30 | -$84.08K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | -$4.04K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |